KWF
INTER-LOCAL: International Clinical Trials in Local Treatment for Rare and Hard-to-Treat Cancers
Full proposal closure: 18 June 2026, 12:00 noon CEST. Pre-proposal phase already closed (22 Jan 2026). Only invited applicants may submit full proposals.
Last verified:
Details
| Funder | KWF |
| Budget | Up to €3M |
| Deadline | 18 June 2026 |
| Consortium | Required — partners from at least 3 of 5 funding countries (Belgium, Netherlands, Spain, Norway, Sweden) |
| Application | 2-stage: pre-proposal (closed 22 Jan 2026) → full proposal (open 27 Apr 2026, closes 18 Jun 2026); rebuttal week 7 Sep 2026; funding decision 27 Oct 2026 |
| Eligible countries | BENLESNOSE |
Eligibility & scope
Supports late-phase (phase 2/3) international clinical trials using radiotherapy or surgery as core experimental interventions for rare cancers (incidence <6/100,000/year) and/or hard-to-treat cancers (5-year survival <25%). Requires partners from ≥3 of 5 funding countries. Only 5 pre-selected projects are invited to submit full proposals. Clinical trial focus with mandatory patient involvement and quality-of-life assessment.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
KWF Proof of Concept 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATKWF Proof of Concept (PoC) Programme – Call 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATProof Of Concept 2026-2
Deadline: 2 Jun 2026INTER-LOCAL: International Funding Call for Local Treatment Strategies in Rare and Hard-to-Treat Cancers
Deadline: 18 Jun 2026INTER-LOCAL: International Funding Call for Clinical Research on Local Treatment Strategies
Deadline: 18 Jun 2026Up to €3M
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free